Published in Osteoporos Int on May 13, 2010
Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med (2013) 2.06
Appropriate osteoporosis treatment by family physicians in response to FRAX vs CAROC reporting: results from a randomized controlled trial. J Clin Densitom (2013) 2.05
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.98
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2012) 1.79
Bone, sweet bone--osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol (2012) 1.73
Osteoporosis imaging: state of the art and advanced imaging. Radiology (2012) 1.58
Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther (2010) 1.48
Bone density in haemophilia: a single institutional cross-sectional study. Haemophilia (2013) 1.47
Incident fractures in HIV-infected individuals: a systematic review and meta-analysis. AIDS (2013) 1.31
Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study. AIDS (2010) 1.19
Is chronic hyponatremia a novel risk factor for hip fracture in the elderly? Nephrol Dial Transplant (2012) 1.06
Current and future treatment options in osteoporosis. Eur J Clin Pharmacol (2011) 0.98
Advances in bone imaging for osteoporosis. Nat Rev Endocrinol (2013) 0.97
What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia. Cost Eff Resour Alloc (2016) 0.95
Cancer-associated bone disease. Osteoporos Int (2013) 0.94
Postmenopausal hormone therapy: risks and benefits. Nat Rev Endocrinol (2013) 0.93
Subjective expectations regarding length and health-related quality of life in Hungary: results from an empirical investigation. Health Expect (2012) 0.93
In Vivo Quantitative MR Imaging of Bound and Pore Water in Cortical Bone. Radiology (2015) 0.93
Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates. Drug Des Devel Ther (2011) 0.90
Collaborative Care for Older Adults with low back pain by family medicine physicians and doctors of chiropractic (COCOA): study protocol for a randomized controlled trial. Trials (2013) 0.88
What's in a name revisited: should osteoporosis and sarcopenia be considered components of "dysmobility syndrome?". Osteoporos Int (2013) 0.88
Stress fracture of the pelvis and lower limbs including atypical femoral fractures-a review. Insights Imaging (2014) 0.88
A customized protocol to assess bone quality in the metacarpal head, metacarpal shaft and distal radius: a high resolution peripheral quantitative computed tomography precision study. BMC Musculoskelet Disord (2013) 0.86
Osteosarcopenic obesity is associated with reduced handgrip strength, walking abilities, and balance in postmenopausal women. Osteoporos Int (2015) 0.84
Perception, knowledge, and use by general practitioners of Belgium of a new WHO tool (FRAX) to assess the 10-year probability of fracture. Rheumatol Int (2012) 0.83
What was your fracture risk evaluated by FRAX® the day before your osteoporotic fracture? Clin Rheumatol (2012) 0.82
Vitamin D insufficiency over 5 years is associated with increased fracture risk-an observational cohort study of elderly women. Osteoporos Int (2014) 0.82
The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010. Osteoporos Int (2014) 0.82
Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. Osteoporos Int (2015) 0.82
An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures. J Bone Miner Res (2013) 0.82
Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women. Osteoporos Int (2011) 0.82
Fall incidence and outcomes of falls in a prospective study of adults with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 0.81
Predictors of non-vertebral fracture in older Chinese males and females: Mr. OS and Ms. OS (Hong Kong). J Bone Miner Metab (2016) 0.79
Exercise and fractures in postmenopausal women. Final results of the controlled Erlangen Fitness and Osteoporosis Prevention Study (EFOPS). Osteoporos Int (2015) 0.79
Effect of Posture Training with Weighted Kypho-Orthosis (WKO) on Improving Balance in Women with Osteoporosis. J Aging Res (2014) 0.79
Prediction of incident hip fracture with the estimated femoral strength by finite element analysis of DXA Scans in the study of osteoporotic fractures. J Bone Miner Res (2014) 0.78
Comparison between frailty index of deficit accumulation and fracture risk assessment tool (FRAX) in prediction of risk of fractures. Bone (2015) 0.78
Severity and pattern of bone mineral loss in endocrine causes of osteoporosis as compared to age-related bone mineral loss. J Postgrad Med (2016) 0.78
Hip fracture in the elderly: a re-analysis of the EPIDOS study with causal Bayesian networks. PLoS One (2015) 0.78
The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer. J Oncol (2012) 0.78
At least one cyclic teriparatide administration can be helpful to delay initial onset of a new osteoporotic vertebral compression fracture. Yonsei Med J (2014) 0.77
Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial. Osteoporos Int (2014) 0.77
Type 1 diabetes and osteoporosis: A review of literature. Indian J Endocrinol Metab (2014) 0.77
Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort. Int J Endocrinol (2013) 0.76
A combination of low serum concentrations of vitamins K1 and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study. Osteoporos Int (2015) 0.76
District nurses' perceptions of osteoporosis management: a qualitative study. Osteoporos Int (2015) 0.76
Multisite quantitative ultrasound for the prediction of fractures over 5 years of follow-up: the Canadian Multicentre Osteoporosis Study. J Bone Miner Res (2013) 0.76
Risks of all-cause and site-specific fractures among hospitalized patients with COPD. Medicine (Baltimore) (2016) 0.75
Predicting return to work among sickness-certified patients in general practice: properties of two assessment tools. Ups J Med Sci (2014) 0.75
Effects of Age and Body Mass Index on Thoracolumbar Spine X-Ray for Diagnosing Osteoporosis in Elderly Women: Tianliao Old People (TOP) Study 07. PLoS One (2016) 0.75
Application of the fracture risk assessment tool (FRAX(®)) and determination of suitable cut-off values during primary screening in specific health check-ups in Japan. J Bone Miner Metab (2013) 0.75
Coronary Artery Calcium Score and Bone Metabolism: A Pilot Study in Postmenopausal Women. J Bone Metab (2017) 0.75
miRNAs in circulation: mirroring bone conditions? J Bone Miner Res (2014) 0.75
Clodronate news of efficacy in osteoporosis. Clin Cases Miner Bone Metab (2016) 0.75
A clinical decision support system for the diagnosis, fracture risks and treatment of osteoporosis. Comput Math Methods Med (2015) 0.75
The Association between the Consumption of Fish/Shellfish and the Risk of Osteoporosis in Men and Postmenopausal Women Aged 50 Years or Older. Nutrients (2016) 0.75
Risk factors for fracture in adult kidney transplant recipients. World J Transplant (2016) 0.75
The use of computed tomography attenuation to evaluate osteoporosis following acute fractures of the thoracic and lumbar vertebra. Geriatr Orthop Surg Rehabil (2014) 0.75
Effect of including historical height and radius BMD measurement on sarco-osteoporosis prevalence. J Cachexia Sarcopenia Muscle (2012) 0.75
Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteria. Rheumatol Int (2012) 0.75
Clinical performance of seven prescreening tools for osteoporosis in Iranian postmenopausal women. Rheumatol Int (2015) 0.75
Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experience. Support Care Cancer (2017) 0.75
How frequent is osteogenesis imperfecta in patients with idiopathic osteoporosis?: Case reports. Medicine (Baltimore) (2017) 0.75
Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada. Osteoporos Int (2017) 0.75
Association of Mental Disorders and Related Medication Use With Risk for Major Osteoporotic Fractures. JAMA Psychiatry (2017) 0.75
Sideways fall-induced impact force and its effect on hip fracture risk: a review. Osteoporos Int (2017) 0.75
Diagnosis of osteoporosis and assessment of fracture risk. Lancet (2002) 7.38
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
Assessment of fracture risk. Osteoporos Int (2004) 5.15
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
Age and bone mass as predictors of fracture in a prospective study. J Clin Invest (1988) 4.46
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int (2001) 3.23
International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res (2002) 3.14
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int (2000) 2.99
A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res (2004) 2.92
The cost-effectiveness of alendronate in the management of osteoporosis. Bone (2007) 2.75
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74
Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72
Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res (2003) 2.61
Alcohol intake as a risk factor for fracture. Osteoporos Int (2004) 2.34
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int (2004) 2.11
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int (2008) 1.77
A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int (2002) 1.70
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX. Bone (2009) 1.41
Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int (2008) 1.39
FRAX assessment of osteoporotic fracture probability in Switzerland. Osteoporos Int (2009) 1.19
Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment. J Clin Densitom (2007) 1.15
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess (2007) 1.09
Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application. Osteoporos Int (2008) 0.96
Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation. Ortop Traumatol Rehabil (2007) 0.93
[Diagnosis and treatment of postmenopausal osteoporosis and osteoporosis in men. German Guidelines Update 2006]. Orthopade (2007) 0.92
Ten-year fracture probability in Hong Kong Southern Chinese according to age and BMD femoral neck T-scores. Osteoporos Int (2009) 0.87
[A FRAX model for the assessment of fracture probability in Belgium]. Rev Med Liege (2009) 0.86
Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int (2005) 0.83
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst (1995) 3.79
A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int (2001) 3.23
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol (1999) 3.02
Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int (2000) 2.99
The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int (2001) 2.81
Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet (2002) 2.76
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74
The components of excess mortality after hip fracture. Bone (2003) 2.63
Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer (1998) 2.51
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg (2002) 2.41
Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg (1997) 2.21
Pitfalls in the external validation of FRAX. Osteoporos Int (2011) 2.21
Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos (2011) 2.14
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int (2004) 2.11
Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys (1992) 2.09
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Ann Oncol (2010) 2.02
Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat (2009) 1.90
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone (2000) 1.89
Long-term follow-up of patients with untreated scoliosis. A study of mortality, causes of death, and symptoms. Spine (Phila Pa 1976) (1992) 1.88
Risk of vertebral fracture in women with rheumatoid arthritis. BMJ (1993) 1.87
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int (2008) 1.77
A high incidence of vertebral fracture in women with breast cancer. Br J Cancer (1999) 1.74
The risk and burden of vertebral fractures in Sweden. Osteoporos Int (2003) 1.74
Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer (1990) 1.73
Acute and long-term increase in fracture risk after hospitalization for stroke. Stroke (2001) 1.73
Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos (2013) 1.72
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J (2007) 1.71
A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int (2002) 1.70
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int (2010) 1.69
Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg (2005) 1.68
The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer (1995) 1.60
The distribution, determinants, and clinical correlates of vertebral osteophytosis: a population based survey. J Rheumatol (1999) 1.60
Position sense acuity is diminished following repetitive low-intensity work to fatigue in a simulated occupational setting. Eur J Appl Physiol (2000) 1.57
Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial. Br J Surg (2013) 1.56
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women. J Clin Oncol (1999) 1.53
Estimation of the parenchymal-cell content of the parathyroid gland, using density-gradient columns. Preliminary report. Acta Pathol Microbiol Scand A (1977) 1.52
Determinants of cholesterol goal attainment at 12 months in patients with hypercholesterolaemia not at consensus goal after 3 months of treatment with lipid-lowering drugs. Int J Clin Pract (2007) 1.50
Use of diphosphonates in hypercalcaemia due to malignancy. Lancet (1990) 1.47
Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis (1994) 1.46
The excess mortality due to periprosthetic femur fracture. A study from the Swedish national hip arthroplasty register. Bone (2007) 1.46
Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int (2008) 1.45
The burden of hospitalised fractures in Sweden. Osteoporos Int (2004) 1.41
Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int (2008) 1.39
Malignant and benign human mammary disease: estrogen binding in relation to clinical data. Cancer (1974) 1.39
The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer (2001) 1.39
Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption. Eur J Haematol (1992) 1.39
Normocalcemic hyperparathyroidism, kidney stones, and idiopathic hypercalciuria. Surgery (1975) 1.38
Clodronate decreases the frequency of skeletal metastases in women with breast cancer. Bone (1996) 1.38
Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study. J Bone Miner Res (1993) 1.38
Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer. Br J Surg (2001) 1.37
The potential impact of new National Osteoporosis Foundation guidance on treatment patterns. Osteoporos Int (2009) 1.36
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int (2000) 1.35
Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis. J Bone Miner Res (1997) 1.35
Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas (2013) 1.34
The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology (Oxford) (1999) 1.34
The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int (2006) 1.31
A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults. Br J Haematol (1998) 1.30
Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone (2002) 1.30
Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int (2010) 1.29
Phosphate status affects the gene expression, protein content and enzymatic activity of UDP-glucose pyrophosphorylase in wild-type and pho mutants of Arabidopsis. Planta (2001) 1.29
The binding of estradiol-17beta to human breast cancers and other tissues in vitro. Cancer Res (1970) 1.27
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25
Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int (2003) 1.25
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24